Neurogenetic Disorders: Novel Treatments and the Role of the Diagnostic Lab
Geraldine McDowell, PhD and Keith Hyland, PhD will discuss the importance of biochemical genetics testing and the consideration of inborn errors of metabolism in the differential diagnosis of neurological disease. MNG and LabCorp’s combined biochemical genetic test menu complements treatments that are currently available and in development, and the combined laboratory and drug development experience make LabCorp and MNG strong partners for clinicians.